28/06/2026
NEW TREATMENT available to slow down myopia!
If your child is short-sighted and needs stronger glasses every year, you’re not alone — and it’s not something you just have to accept. Left unchecked, high myopia carries real risks later in life, including a greater chance of retinal detachment and glaucoma. Slowing progression now gives your child the best chance of healthier eyes for life.
Ryjunea is a prescription eye drop containing a low dose of atropine (0.01%), specially designed to slow down the progression of myopia. At this very low dose, most children experience little to no side effects, while the drops quietly work in the background to stop their prescription worsening as quickly as it otherwise would.
Until recently, myopia management lenses (MiYOSMART, Stellest, MyoVision, etc.) were the only option available to families in the UK looking to slow their child’s myopia progression. The arrival of Ryjunea now gives eye care professionals a second clinically proven tool.
Myopia management lenses are a well-established and effective option but every child is different, and what works well for one may not suit another. Having more than one clinically proven treatment available means your eye care professional can tailor the approach to your child’s lifestyle, prescription, and how quickly their myopia is progressing. For some children, a combination of both drops and specialist lenses may even offer the best results. More choices means better, more personalised care.
Contact me ([email protected]) about whether atropine drops, myopia management lenses, or a combination of both could be right for your child.
